To target cellular senescence in diabetic kidney disease: the known and the unknown
Open Access
- 14 August 2024
- journal article
- review article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 138 (16) , 991-1007
Abstract
Cellular senescence represents a condition of irreversible cell cycle arrest, characterized by heightened senescence-associated beta-galactosidase (SA-β-Gal) activity, senescence-associated secretory phenotype (SASP), and activation of the DNA damage response (DDR). Diabetic kidney disease (DKD) is a significant contributor to end-stage renal disease (ESRD) globally, with ongoing unmet needs in terms of current treatments. The role of senescence in the pathogenesis of DKD has attracted substantial attention with evidence of premature senescence in this condition. The process of cellular senescence in DKD appears to be associated with mitochondrial redox pathways, autophagy, and endoplasmic reticulum (ER) stress. Increasing accumulation of senescent cells in the diabetic kidney not only leads to an impaired capacity for repair of renal injury, but also the secretion of pro-inflammatory and profibrotic cytokines and growth factors causing inflammation and fibrosis. Current treatments for diabetes exhibit varying degrees of renoprotection, potentially via mitigation of senescence in the diabetic kidney. Targeting senescent cell clearance through pharmaceutical interventions could emerge as a promising strategy for preventing and treating DKD. In this paper, we review the current understanding of senescence in DKD and summarize the possible therapeutic interventions relevant to senescence in this field.Keywords
Funding Information
- National Health and Medical Research Council (APP2011355)
This publication has 175 references indexed in Scilit:
- Bradykinin protects cardiac c‐kit positive cells from high‐glucose‐induced senescence through B2 receptor signaling pathwayJournal of Cellular Biochemistry, 2019
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal RiskJAMA, 2019
- DNA damage foci: Meaning and significanceEnvironmental and Molecular Mutagenesis, 2015
- Detection of β-Galactosidase Activity: X-gal Staining2012
- Cellular senescence and tumor suppressor gene p16International Journal of Cancer, 2011
- Uncoupling the Senescent Phenotype from Telomere Shortening in Hydrogen Peroxide-Treated FibroblastsExperimental Cell Research, 2001
- Is β-Galactosidase Staining a Marker of Senescence in Vitro and in Vivo?Experimental Cell Research, 2000
- Transforming Growth Factor β Triggers Two Independent-Senescence Programs in Cancer CellsBiochemical and Biophysical Research Communications, 1999
- Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression ScreenExperimental Cell Research, 1994
- β‐Galactosidase—An indicator of the maturational stage of mouse and human mononuclear phagocytesJournal of Cellular Physiology, 1982